Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults.
Phase of Trial: Phase I
Latest Information Update: 20 May 2017
At a glance
- Drugs GSK 1437173A (Primary)
- Indications Herpes zoster
- Focus Adverse reactions; Pharmacodynamics
- 12 Nov 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 12 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2010 New trial record